The Impella heart pumps are used in critical care settings to help a patient’s heart pump blood, and they can be monitored remotely through the app.
Abiomed told the FDA these devices are classified as Non-Device Clinical Decision Support Software and Non-Device Medical Device Data Systems, but the regulatory agency disagrees.
“Though some functions of the Impella Connect System may be Non-Device-MDDS [the product’s alarms] provide patient-specific medical information to detect a life-threatening condition and display time-critical alarms intended to notify a healthcare provider,” the FDA said in its Oct. 10 letter. Because of this, the Impella pumps require premarket approval.
Abiomed is working with the FDA, a spokesperson said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.